How To Make The Backyard The Style Center Of Your Home

For many homeowners, the backyard is not at the forefront of their home-design plans. But procrastination can be an advantage when it comes to outdoor living. By the time many people consider the backyard, they have developed a strong sense of their own décor personality.

Most consumers’ design styles can be classified as traditionalist, bohemian, modern, eclectic, rustic or industrial, according to Belgard, a company dedicated to outdoor living design and elements for patio spaces and beyond.

Fortunately, there are backyard design plans to suit any taste, as well as any budget. Some design elements that might have particular appeal to different décor personalities include:

*For the traditionalist: Classic comfort. What is the primary purpose of a patio? A place for sitting and relaxing. Attractive, sturdy pavers in appealing patterns provide easy walking and an artistic base for conversation nooks of tables, chairs, planters, and picnic tables.

*For the bohemian: Fire pit. Fire pits are an easy way to promote cozy gathering for all ages. And everyone can appreciate freedom from bugs; wood fires can help hold mosquitoes at bay.

*For the modernist: Multiple levels. Homeowners seeking a modern look can consider a range of options for walkways and pavers that might include steps and slopes to wind through a terraced garden.

*For the eclectic: Water features. But not just for swimming. Homeowners can show off an eclectic backyard style with a fountain, fish pond, or other water feature that makes a splash.

*For the rustic: Eating out. Cooking outdoors can reach a new level, as advanced outdoor kitchen units allow guests to help with meal preparation or just chat with the host/chef while enjoying the outdoor setting.

*For the industrial: Unique lighting is a way to make a statement and set a mood in an outdoor setting. Some ways to get creative with light include not only hardscape lighting and illuminated planters, but short-term elements such as lighting fixtures that highlight cool metals and metallics for a more urban, industrial vibe.

Belgard, part of Oldcastle Architectural, was established in 1995 and remains a respected source of durable, classic, stylish outdoor-living products and a resource for design ideas to help homeowners take on backyard design with confidence.

Read More

Biotech Company Files Two More Patents For Proprietary Cancer Cure

It is the disease that cost more than 8 million people their lives in 2012 and sees 14 million diagnosed every year. It comes in many forms and there is no cure — yet. Part of the problem in finding a cure is that while scientists used to think they knew how cancer operated, it is only in the last decade that they have been able to better understand this insidious disease. Cancer is much more complex than originally thought. But one company thinks it may have a solution. Propanc Health Group Corporation (OTCB: PPCH) is focusing on developing treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers.

Up until recently, the company had four patent applications for its lead product, PRP, a proenzyme, anti-cancer compound which targets cancer stem cell eradication while sparing normal stem cells. Now the company has added two more to its portfolio.

“I have no doubt PRP represents a new therapeutic drug class with significant potential [because] when confirming PRP’s effectiveness across a broad range of cancers, we also confirmed a synergistic response between the two proenzymes to the majority of cancer cell lines tested,” says Dr. Julian Kenyon, Propane’s Chief Scientific Officer. “We also noticed that for some cancer types, multiple combinations of the two proenzymes proved to be effective.”

Propanc recently met with the Medicines and Healthcare Products Regulatory Agency (MHRA) to discuss formal pre-clinical and clinical development of PRP. In addition, the company said it intends to apply for orphan drug designation for pancreatic and ovarian cancers in the US and Europe in the near future.

With the advent of five new patents, this biotech company is catching the eye of investors. In March 2016, Propanc received more than $1 million from an institutional investor for the purpose of fast-tracking its pre-clinical activities, bringing its received total to approximately $3.6 million.

According to Global Analyst Reports, the combined world market for pancreatic, ovarian and colorectal cancers is expected to reach more than $12 billion by 2020.

Read More